Page 126 - Read Online

Melnik et al. J Transl Genet Genom 2022;6:1-45 https://dx.doi.org/10.20517/jtgg.2021.37 Page 29

141. Gennigens C, Menetrier-Caux C, Droz JP. Insulin-like growth factor (IGF) family and prostate cancer. Crit Rev Oncol Hematol
2006;58:124-45. DOI PubMed
142. Kawada M, Inoue H, Masuda T, Ikeda D. Insulin-like growth factor I secreted from prostate stromal cells mediates tumor-stromal cell
interactions of prostate cancer. Cancer Res 2006;66:4419-25. DOI PubMed
143. Wu JD, Haugk K, Woodke L, Nelson P, Coleman I, Plymate SR. Interaction of IGF signaling and the androgen receptor in prostate
cancer progression. J Cell Biochem 2006;99:392-401. DOI PubMed
144. Kawada M, Inoue H, Arakawa M, Ikeda D. Transforming growth factor-beta1 modulates tumor-stromal cell interactions of prostate
cancer through insulin-like growth factor-I. Anticancer Res 2008;28:721-30. PubMed
145. Kojima S, Inahara M, Suzuki H, Ichikawa T, Furuya Y. Implications of insulin-like growth factor-I for prostate cancer therapies. Int J
Urol 2009;16:161-7. DOI PubMed
146. Nimptsch K, Platz EA, Pollak MN, et al. Plasma insulin-like growth factor 1 is positively associated with low-grade prostate cancer
in the Health Professionals Follow-up Study 1993-2004. Int J Cancer 2011;128:660-7. DOI PubMed PMC
147. Heidegger I, Massoner P, Sampson N, Klocker H. The insulin-like growth factor (IGF) axis as an anticancer target in prostate cancer.
Cancer Lett 2015;367:113-21. DOI PubMed
148. Cao Y, Nimptsch K, Shui IM, et al. Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer. Int J Cancer 2015;136:2418-
26. DOI PubMed PMC
149. Ahearn TU, Peisch S, Pettersson A, et al; Transdisciplinary Prostate Cancer Partnership (ToPCaP). Expression of IGF/insulin
receptor in prostate cancer tissue and progression to lethal disease. Carcinogenesis 2018;39:1431-7. DOI PubMed PMC
150. Kim M, Kim JW, Kim JK, et al. Association between serum levels of insulin-like growth factor-1, bioavailable testosterone, and
pathologic Gleason score. Cancer Med 2018;7:4170-80. DOI PubMed PMC
151. Ohishi T, Abe H, Sakashita C, et al. Inhibition of mitochondria ATP synthase suppresses prostate cancer growth through reduced
insulin-like growth factor-1 secretion by prostate stromal cells. Int J Cancer 2020;146:3474-84. DOI PubMed
152. Melnik BC, John SM, Schmitz G. Milk is not just food but most likely a genetic transfection system activating mTORC1 signaling
for postnatal growth. Nutr J 2013;12:103. DOI PubMed PMC
153. Melnik BC, Schmitz G. Milk's role as an epigenetic regulator in health and disease. Diseases 2017;5:12. DOI PubMed PMC
154. Vasconcelos A, Santos T, Ravasco P, Neves PM. Dairy products: is there an impact on promotion of prostate cancer? Front Nutr
2019;6:62. DOI PubMed PMC
155. Pereira PC. Milk nutritional composition and its role in human health. Nutrition 2014;30:619-27. DOI PubMed
156. Tunick MH, Van Hekken DL. Dairy products and health: recent insights. J Agric Food Chem 2015;63:9381-8. DOI PubMed
157. Thorning TK, Raben A, Tholstrup T, Soedamah-Muthu SS, Givens I, Astrup A. Milk and dairy products: good or bad for human
health? Food Nutr Res 2016;60:32527. DOI PubMed PMC
158. Gil Á, Ortega RM. Introduction and executive summary of the supplement, role of milk and dairy products in health and prevention
of noncommunicable chronic diseases: a series of systematic reviews. Adv Nutr 2019;10:S67-73. DOI PubMed PMC
159. Timon CM, O'Connor A, Bhargava N, Gibney ER, Feeney EL. Dairy consumption and metabolic health. Nutrients 2020;12:3040.
DOI PubMed PMC
160. Melnik BC. Lifetime impact of Cow's milk on overactivation of mTORC1: from fetal to childhood overgrowth, acne, diabetes,
cancers, and neurodegeneration. Biomolecules 2021;11:404. DOI PubMed PMC
161. Willett WC, Ludwig DS. Milk and health. N Engl J Med 2020;382:644-54. DOI PubMed
162. Michaëlsson K, Wolk A, Langenskiöld S, et al. Milk intake and risk of mortality and fractures in women and men: cohort studies.
BMJ 2014;349:g6015. DOI PubMed PMC
163. Tognon G, Nilsson LM, Shungin D, et al. Nonfermented milk and other dairy products: associations with all-cause mortality. Am J
Clin Nutr 2017;105:1502-11. DOI PubMed PMC
164. Michaëlsson K, Wolk A, Melhus H, Byberg L. Milk, fruit and vegetable, and total antioxidant intakes in relation to mortality rates:
cohort studies in women and men. Am J Epidemiol 2017;185:345-61. DOI PubMed PMC
165. Michaëlsson K, Byberg L. Mixing of apples and oranges in milk research: a cohort analysis of non-fermented milk intake and all-
cause mortality. Nutrients 2020;12:1393. DOI PubMed PMC
166. Torniainen S, Hedelin M, Autio V, et al. Lactase persistence, dietary intake of milk, and the risk for prostate cancer in Sweden and
Finland. Cancer Epidemiol Biomarkers Prev 2007;16:956-61. DOI PubMed
167. Agarwal MM, Rana SV, Mandal AK, et al. Lactose intolerance in prostate cancer patients: incidence and associated factors. Scand J
Gastroenterol 2008;43:270-6. DOI PubMed
168. Torfadottir JE, Steingrimsdottir L, Mucci L, et al. Milk intake in early life and risk of advanced prostate cancer. Am J Epidemiol
2012;175:144-53. DOI PubMed PMC
169. Pettersson A, Kasperzyk JL, Kenfield SA, et al. Milk and dairy consumption among men with prostate cancer and risk of metastases
and prostate cancer death. Cancer Epidemiol Biomarkers Prev 2012;21:428-36. DOI PubMed PMC
170. Song Y, Chavarro JE, Cao Y, et al. Whole milk intake is associated with prostate cancer-specific mortality among U.S. male
physicians. J Nutr 2013;143:189-96. DOI PubMed PMC
171. Yang M, Kenfield SA, Van Blarigan EL, et al. Dairy intake after prostate cancer diagnosis in relation to disease-specific and total
mortality. Int J Cancer 2015;137:2462-9. DOI PubMed PMC
172. Lu W, Chen H, Niu Y, Wu H, Xia D, Wu Y. Dairy products intake and cancer mortality risk: a meta-analysis of 11 population-based
cohort studies. Nutr J 2016;15:91. DOI PubMed PMC
173. Downer MK, Batista JL, Mucci LA, et al. Dairy intake in relation to prostate cancer survival. Int J Cancer 2017;140:2060-9. DOI